International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Impact of Diabetes on Heart

Author(s) Zoya Zabeen, Dr. Uday Singh Yadav
Country India
Abstract Diabetes is sometimes described as the "coronary equivalent." A coronary equivalent refers to a condition or risk factor that increases the likelihood of developing coronary artery disease (CAD), a condition characterized by the narrowing or blockage of blood vessels supplying the heart. Identifying and managing these coronary equivalents is crucial for preventing and mitigating the severity of CAD". These illnesses are regarded as coronary equivalents since they have been linked to a higher risk of CAD and would need the same therapies and management techniques as CAD. Diabetes has the potential to significantly affect the heart and circulatory system. Additionally, diabetes patients are more likely to smoke, be obese, be inactive physically, and have other heart disease risk factors. some diabetic treatments, including insulin, and sulfonylureas, might raise the danger of hypoglycaemia, which can cause heart rhythm problems and even sudden death. The risk of heart disease can be decreased by preventing and controlling diabetes by lifestyle modifications like consistent exercise, a balanced diet, and weight management, as well as with the use of the proper medical care. Diabetes complications, especially impact on heart and circulatory system, must be prevented and managed by closely monitoring blood sugar, blood pressure, and cholesterol levels.

Lowering cardiovascular risk factors and treating the illness he high frequency of health issues and death from cardiovascular disease in those at risk for and with diabetes has made this a more crucial and all-encompassing component of diabetes care. Additionally, there are drugs that can aid in lowering risk factors and the prevalence of heart-related illnesses. With precise guidelines, more attention is placed on lowering the likelihood of developing heart and kidney issues and safeguarding these organs from harm. For patients with atherosclerotic cardiovascular disease (ASCVD) and/or those at high risk for heart and kidney disease, heart failure, and chronic kidney disease, the recommendations center on selecting drugs properly. SGLT2 inhibitors or GLP-1 receptor agonists are typically the recommended treatments. More than ever, there are drugs available now that help treat or prevent these additional illnesses as well as blood glucose levels.
The Standards synchronized the blood pressure target with other significant organizations that established these recommendations. A systolic blood pressure of less than 130 mmHg or a diastolic blood pressure of less than 80 mmHg (130/80 mmHg) is now considered high blood pressure.

For adults with diabetes and risk factors for ASCVD who are 40 to 75 years old, the target LDL-cholesterol level is 70 mg/dL, and for those who already have ASCVD, the target LDL-cholesterol level is 55 mg/dL. In addition, if the goal level is not reached, it is advised to achieve an LDL reduction of 50% or more from the beginning point LDL with a high intensity statin drug and then use a different drug, such as ezetimibe or a PCSK9, if necessary. This emphasizes the significance of managing and preventing cardiovascular disease.
Keywords Diabetes, cardiovascular disease, CA, CVD prevention, modern lifestyle
Field Biology > Medical / Physiology
Published In Volume 6, Issue 1, January-February 2024
Published On 2024-02-28
Cite This Impact of Diabetes on Heart - Zoya Zabeen, Dr. Uday Singh Yadav - IJFMR Volume 6, Issue 1, January-February 2024. DOI 10.36948/ijfmr.2024.v06i01.14123
DOI https://doi.org/10.36948/ijfmr.2024.v06i01.14123
Short DOI https://doi.org/gtktf3
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com